8-KThe WireRoutine
Shareholder Vote
Filed May 28, 2026 · 1mo ago · Accession 0001193125-26-245203
Plain English
Teva Pharmaceutical Industries Limited held its Annual Meeting on May 28, 2026, where shareholders voted on the appointment of a director, executive compensation, and the appointment of an independent registered public accounting firm.
Filing details
- Ticker
- TEVA
- CIK
- 818686
- Form type
- 8-K
- Filing date
- May 28, 2026
- Report date
- May 28, 2026
- Document
- d342755d8k.htm
- Size
- 139 KB